Comparative analysis of three NGS platforms assessing tumor mutational burden and mutational landscape in resectable non-small cell lung cancer

被引：0
|
作者：
Lee, J. B. [1 ]
Choi, S. J. [2 ]
Kim, J. H. [2 ]
Hong, M. H. [1 ]
Cho, B. C. [1 ]
Lim, S. M. [1 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Yonsei Canc Ctr, Div Oncol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
481P
引用
收藏
页码：S1649 / S1649
页数：1
相关论文
共 50 条
  • [21] Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer
    Alborelli, Ilaria
    Leonards, Katharina
    Rothschild, Sacha, I
    Leuenberger, Laura P.
    Prince, Spasenija Savic
    Mertz, Kirsten D.
    Poechtrager, Severin
    Buess, Martin
    Zippelius, Alfred
    Laubli, Heinz
    Haegele, Jasmin
    Tolnay, Markus
    Bubendorf, Lukas
    Quagliata, Luca
    Jermann, Philip
    JOURNAL OF PATHOLOGY, 2020, 250 (01): : 19 - 29
  • [22] Tumor mutational burden assessed by a targeted NGS assay predicts benefit from immune checkpoint inhibitors in non-small cell lung cancer
    Rothschild, S. I.
    Jermann, P.
    Savic, S.
    Mertz, K. D.
    Poechtrager, S.
    Zippelius, A.
    Quagliata, L.
    Bubendorf, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 234 - 234
  • [23] Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer
    Choi, Su-Jin
    Lee, Jii Bum
    Kim, Jae Hwan
    Hong, Min Hee
    Cho, Byoung Chul
    Lim, Sun Min
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [24] Blood tumor mutational burden (bTMB) from circulating tumor DNA (ctDNA) as a biomarker for both mutational status and tumor burden in non-small cell lung cancer (NSCLC)
    Davis, Andrew A.
    Galvez, Carlos
    Pan, Alan
    Mohindra, Nisha
    Villaflor, Victoria
    Chae, Young Kwang
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
    Chae, Young Kwang
    Davis, Andrew A.
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Iams, Wade T.
    Cruz, Marcelo R.
    Tamragouri, Keerthi
    Rhee, Kyunghoon
    Mohindra, Nisha
    Villaflor, Victoria
    Park, Wungki
    Lopes, Gilberto
    Giles, Francis J.
    ONCOLOGIST, 2019, 24 (06): : 820 - 828
  • [26] Clinical and technical insights of tumour mutational burden in non-small cell lung cancer
    Meri-Abad, Marina
    Moreno-Manuel, Andrea
    Garcia, Sandra Gallach
    Calabuig-Farinas, Silvia
    Perez, Rafael Sirera
    Herrero, Carlos Camps
    Jantus-Lewintre, Eloisa
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 182
  • [27] Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer
    Wei, Xue-Wu
    Gao, Xin
    Zhang, Xu-Chao
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Wu, Yi-Long
    Zhou, Qing
    THORACIC CANCER, 2020, 11 (06) : 1512 - 1521
  • [28] Impact of tumor mutational burden on overall survival in patients with non-small cell lung cancer treated with immunotherapy
    Awad, Mark
    Mahadevan, Navin
    Polio, Andrew
    Vokes, Natalie
    Aguilar, Elizabeth
    Ricciuti, Biagio
    Lamberti, Giuseppe
    Recondo, Gonzalo
    Leonardi, Giulia
    Adeni, Anika
    Janne, Pasi
    Van Allen, Eliezer
    Albayrak, Adem
    Umeton, Renato
    Sholl, Lynette
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [29] Analytic validation of tumor mutational burden as a companion diagnostic for combination immunotherapy in non-small cell lung cancer
    Fabrizio, D. A.
    Milbury, C.
    Yip, W-K.
    Ramamurthy, L.
    Bai, X.
    Pattani, V.
    Maness, P.
    Cowen, A.
    Fedorchak, K.
    Ma, P.
    Frampton, G. M.
    Connelly, C.
    Li, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 16 - 16
  • [30] Non-Small Cell Lung Cancer as a Precision Oncology Paradigm: Emerging Targets and Tumor Mutational Burden (TMB)
    Tafe, Laura J.
    ADVANCES IN ANATOMIC PATHOLOGY, 2020, 27 (01) : 3 - 10
12345